Early reduction in ctDNA is associated with overall survival (OS) on tebentafusp in previously treated metastatic uveal melanoma patients

Circulating tumor DNA based molecular residual disease detection for treatment monitoring in advanced melanoma patients

10-Year Anora Clinical Study

ACOG Practice Bulletin: Screening for Fetal Chromosomal Abnormalities

BESPOKE study of ctDNA guided immunotherapy

Prospective, multi-center clinical study examining the role of ctDNA in immune checkpoint blockade treatment response monitoring.